Marques C. Olimpio
Botucatu, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Triiodothyronine (T3) increases the expression of the amphiregulin (AREG) oncogene by activating extranuclear pathways in MCF-7 breast cancer cells.
Journal: Archives of endocrinology and metabolism
Published: March 08, 2024
Effects of Triiodothyronine on Human Osteoblast-Like Cells: Novel Insights From a Global Transcriptome Analysis.
Journal: Frontiers in cell and developmental biology
Published: February 28, 2022
Triiodothyronine activated extranuclear pathways upregulate adiponectin and leptin in murine adipocytes.
Journal: Molecular and cellular endocrinology
Published: July 31, 2019
Disruptive Effect of Organotin on Thyroid Gland Function Might Contribute to Hypothyroidism.
Journal: International journal of endocrinology
Published: July 17, 2018
Triiodothyronine (T3) induces HIF1A and TGFA expression in MCF7 cells by activating PI3K.
Journal: Life sciences
Published: November 26, 2015
Short-term effects of triiodothyronine on thyroid hormone receptor alpha by PI3K pathway in adipocytes, 3T3-L1.
Journal: Arquivos brasileiros de endocrinologia e metabologia
Published: February 20, 2014
Triiodothyronine modulates the expression of leptin and adiponectin in 3T3-L1 adipocytes.
Journal: Einstein (Sao Paulo, Brazil)
Published: February 16, 2014
Triiodothyronine and breast cancer.
Journal: World journal of clinical oncology
Published: January 10, 2014
Last Updated: 09/26/2026